What does Dr. Astrid Vermeersch fysische geneeskunde do?

Dr. Astrid Vermeersch fysische geneeskunde is a specialist medical practice in Mechelen. Private Limited, started on 1 February 2023, 1 establishment.

What is the address of Dr. Astrid Vermeersch fysische geneeskunde?

The registered office of Dr. Astrid Vermeersch fysische geneeskunde is located at Koolstraat 14, 2800 Mechelen.

Is Dr. Astrid Vermeersch fysische geneeskunde still active?

Yes. According to the CBE (20 September 2026) Dr. Astrid Vermeersch fysische geneeskunde is active, legal situation “Normale toestand”, started on 1 February 2023.

Is Dr. Astrid Vermeersch fysische geneeskunde registered on Peppol?

Yes, Dr. Astrid Vermeersch fysische geneeskunde is registered on the Peppol network with ID 0208:0797880131.

What is the enterprise number of Dr. Astrid Vermeersch fysische geneeskunde?

The enterprise number of Dr. Astrid Vermeersch fysische geneeskunde is BE0797880131.

When was Dr. Astrid Vermeersch fysische geneeskunde founded?

Dr. Astrid Vermeersch fysische geneeskunde was founded on 1 February 2023.

Is Dr. Astrid Vermeersch fysische geneeskunde a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 February 2023; 4 annual accounts filed, latest fiscal year 2026.

How much profit did Dr. Astrid Vermeersch fysische geneeskunde make in 2026?

Dr. Astrid Vermeersch fysische geneeskunde recorded a loss after taxes of € 8,840 in financial year 2026.

What is the revenue of Dr. Astrid Vermeersch fysische geneeskunde?

As a small company, Dr. Astrid Vermeersch fysische geneeskunde is not required to publish revenue in its annual accounts. In financial year 2026, its added value was € -8,602.

Dr. Astrid Vermeersch fysische geneeskunde (Private Limited)

Dossier Dr. Astrid Vermeersch fysische geneeskunde, printed on 20 September 2026 from databakkes.be/en/0797880131/dr-astrid-vermeersch-fysische-geneeskunde. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2026

Dr. Astrid Vermeersch fysische geneeskunde from Mechelen, company number BE0797880131, closed financial year 2026 with a result of € -8,840 after tax. For that financial year Dr. Astrid Vermeersch fysische geneeskunde recorded a gross margin of € -8,602 and equity of € 5,000. Compared with financial year 2025, the result moved from € 25,696 to € -8,840. The company made a loss. The buffer shrank hard: equity is 99 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on September 11, 2026.

What it is worth Shrank hard

€ 5,000

▼ 99% vs 2025

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -8,840

▼ still € 25,696 profit in 2025

Profit after tax over the fiscal year.

Cash in the bank

€ 268,046

▼ 3% vs 2025

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 0.

Debts at end 2026

Bank debt

None

No bank loans on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2023	2024	2025	2026	Change 2025 → 2026
Gross margin	€ 259,445 Gross margin 2023: € 259,445 First fiscal year in the series	€ 237,019 Gross margin 2024: € 237,019 ▼ 9% vs 2023 (€ 259,445) Unfavourable step	€ 66,541 Gross margin 2025: € 66,541 ▼ 72% vs 2024 (€ 237,019) Unfavourable step	€ -8,602 Gross margin 2026: € -8,602 ▼ € 75,143 vs 2025 (€ 66,541) Unfavourable step	▼ € 75,143
Profit after taxes	€ 180,615 Profit after taxes 2023: € 180,615 First fiscal year in the series	€ 156,523 Profit after taxes 2024: € 156,523 ▼ 13% vs 2023 (€ 180,615) Unfavourable step	€ 25,696 Profit after taxes 2025: € 25,696 ▼ 84% vs 2024 (€ 156,523) Unfavourable step	€ -8,840 Profit after taxes 2026: € -8,840 ▼ € 34,537 vs 2025 (€ 25,696) Unfavourable step	▼ € 34,537
Equity	€ 185,615 Equity 2023: € 185,615 First fiscal year in the series	€ 342,139 Equity 2024: € 342,139 ▲ 84% vs 2023 (€ 185,615) Favourable step	€ 367,835 Equity 2025: € 367,835 ▲ 8% vs 2024 (€ 342,139) Favourable step	€ 5,000 Equity 2026: € 5,000 ▼ 99% vs 2025 (€ 367,835) Unfavourable step	▼ 99%
Total debts	€ 29,416 Total debts 2023: € 29,416 First fiscal year in the series	€ 8,299 Total debts 2024: € 8,299 ▼ 72% vs 2023 (€ 29,416) Favourable step	€ 407 Total debts 2025: € 407 ▼ 95% vs 2024 (€ 8,299) Favourable step	€ 353,994 Total debts 2026: € 353,994 ▲ € 353,587 vs 2025 (€ 407) Unfavourable step	▲ € 353,587
Cash	€ 107,561 Cash 2023: € 107,561 First fiscal year in the series	€ 230,422 Cash 2024: € 230,422 ▲ 114% vs 2023 (€ 107,561) Favourable step	€ 275,442 Cash 2025: € 275,442 ▲ 20% vs 2024 (€ 230,422) Favourable step	€ 268,046 Cash 2026: € 268,046 ▼ 3% vs 2025 (€ 275,442) Unfavourable step	▼ 3%
Land & buildings	-	€ 21,875 Land & buildings 2024: € 21,875 First fiscal year in the series	€ 19,611 Land & buildings 2025: € 19,611 ▼ 10% vs 2024 (€ 21,875) Unchanged	€ 0 Land & buildings 2026: € 0 ▼ 100% vs 2025 (€ 19,611) Unchanged	▼ 100%
Retained profit	€ 180,615 Retained profit 2023: € 180,615 First fiscal year in the series	€ 337,139 Retained profit 2024: € 337,139 ▲ 87% vs 2023 (€ 180,615) Favourable step	€ 362,835 Retained profit 2025: € 362,835 ▲ 8% vs 2024 (€ 337,139) Favourable step	€ 0 Retained profit 2026: € 0 ▼ 100% vs 2025 (€ 362,835) Unfavourable step	▼ 100%
Dividend	€ 0 Dividend 2023: € 0 First fiscal year in the series	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged	€ 353,994 Dividend 2026: € 353,994 Unchanged (€ 0) Unchanged
Balance sheet total	€ 215,031 Balance sheet total 2023: € 215,031 First fiscal year in the series	€ 350,437 Balance sheet total 2024: € 350,437 ▲ 63% vs 2023 (€ 215,031) Unchanged	€ 368,242 Balance sheet total 2025: € 368,242 ▲ 5% vs 2024 (€ 350,437) Unchanged	€ 358,994 Balance sheet total 2026: € 358,994 ▼ 3% vs 2025 (€ 368,242) Unchanged	▼ 3%

Key figures of Dr. Astrid Vermeersch fysische geneeskunde, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 8 April 2028.

What happened to Dr. Astrid Vermeersch fysische geneeskunde?

What happened at Dr. Astrid Vermeersch fysische geneeskunde in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 11, 2026 New annual accounts for financial year 2026: loss of € 8,840 (▼ € 34,537 vs 2025). Source: NBB ↗
Feb 1, 2023 New establishment in Mechelen. KBO
Feb 1, 2023 Start of the company according to the CBE. KBO

In short

From € 180,615 profit in 2023 to € 8,840 loss in 2026.

Paid € 155,845 in corporate taxes since 2023.

Best year ever: 2023, with € 180,615 profit.

Paid out € 353,994 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Astrid Vermeersch fysische geneeskunde? We notify you, reason included.

Follow Dr. Astrid Vermeersch fysische geneeskunde

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Establishments

Establishment units

Physical locations of this company

Registered office

Koolstraat 14

2800 Mechelen

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

School voor Manuele Geneeskunde

€ 5,367 gross margin · 2023

DR. TOM VAN DEN MOOTER

€ 512,454 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0797.880.131
VAT number: BE 0797.880.131
Registered office: Koolstraat 14, 2800 Mechelen
Names & denominations: Dr. Astrid Vermeersch fysische geneeskunde
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 1 February 2023
Peppol: Active · Active since 22 Oct 2025
Contact: [email protected]
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗

Dr. Astrid Vermeersch fysische geneeskunde